Teleflex Incorporated a leading global provider of medical technologies announced the FDA has cleared the QuikClot Control+ Hemostatic Device to include mild and moderate bleeding in cardiac surgical procedures and bone surface bleeding following a sternotomy
To explore whether disturbed fibrin polymerization is the main problem underlying dilutional coagulopathy and can be reversed by fibrinogen administration, we conducted a prospective study using modified...
Baxter International Inc. announced the publication of two new analyses of real-world data regarding the use of Floseal Hemostatic Matrix...
Unmet patient needs in MS management
High-efficacy therapies
Novartis announced at ECTRIMS conference findings from an international multiple sclerosis (MS) registry and a US health claims data base...
Baxter International Inc. announced the launch of Hemopatch Sealing Hemostat, a novel collagen-based hemostatic device, following CE mark approval in...
Containing relevant Learning Zones, guidelines, trials and news.
Take a look into hemostatic characteristics during pediatric liver transplantation using the thromboelastometry (ROTEMĀ®) test.